Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$37.50
+19.24%today
MKT CAP
$4.0B
+12.3% · 1Y
Earnings History
+18.3%
+2.8%
-6.3%
+3.7%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$37.50
Low
$20.00
Analyst Mean
$43.25
High
$52.00
12 analystsBuy
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-16.7x
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
ROE-38.1%
Debt / Equity0.77x
Free Cash Flow$-90,171,248
Insider Ownership0.5%
Institutional Ownership115.5%
Short % of Float13.26%
Days to Cover12.0d
1 Week+23.0%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| DONOVAN JOANNE M | Officer | Sale | 55,230 | $31.29 | $1.74M | 2026-05-05 |
| DONOVAN JOANNE M | Officer | Conversion | 50,000 | $7.08 | $0.35M | 2026-05-05 |
| DONOVAN JOANNE M | Officer | Sale | 28,662 | $32.31 | $0.93M | 2026-04-01 |
| DONOVAN JOANNE M | Officer | Conversion | 28,662 | $7.08 | $0.20M | 2026-04-01 |
| FOX JONATHAN C | Director | Stock | 339 | $0.00 | $0.00M | 2026-04-01 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Orbimed Advisors LLC. | institution | 14.44% | $0.55B | +0.00% | 2025-12-31 |
| RA Capital Management, L.P. | institution | 9.70% | $0.37B | +0.00% | 2025-12-31 |
| Blackrock Inc. | institution | 6.17% | $0.23B | +4.39% | 2025-12-31 |
| Baker Bros. Advisors, LP | institution | 6.12% | $0.23B | -9.99% | 2025-12-31 |
| Paradigm Biocapital Advisors LP | institution | 6.09% | $0.23B | +6.01% | 2025-12-31 |
| Novo Holdings A/S | institution | 4.98% | $0.19B | +0.00% | 2025-12-31 |
| Braidwell LP | institution | 4.85% | $0.18B | +0.00% | 2025-12-31 |
| Vanguard Group Inc | institution | 4.53% | $0.17B | +1.41% | 2025-12-31 |
| Janus Henderson Group PLC | institution | 4.25% | $0.16B | -8.28% | 2025-12-31 |
| Siren, L.L.C. | institution | 4.21% | $0.16B | +16.24% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.63% | $0.10B | +0.29% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 ETF | fund | 1.52% | $0.06B | +0.01% | 2026-03-31 |
| American Century Mutual Funds, Inc.-Small Cap Growth Fund | fund | 0.80% | $0.03B | -1.96% | 2026-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.74% | $0.03B | +2.37% | 2025-12-31 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | fund | 0.74% | $0.03B | +2.43% | 2026-03-31 |
| -Victory Pioneer Select Mid Cap Growth Fund | fund | 0.68% | $0.03B | +8.56% | 2026-02-28 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | fund | 0.62% | $0.02B | +1.07% | 2026-02-28 |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | fund | 0.57% | $0.02B | -14.81% | 2025-12-31 |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | fund | 0.53% | $0.02B | +0.00% | 2025-12-31 |
| iShares Trust-iShares Biotechnology ETF | fund | 0.53% | $0.02B | +0.61% | 2026-03-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for EWTX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.